| Phyllis Shnaider, SW | |
|
1514 Jefferson Hwy, New Orleans, LA 70121-2429 | |
| (504) 842-4000 | |
| Not Available |
| Full Name | Phyllis Shnaider |
|---|---|
| Gender | Female |
| Speciality | Clinical Social Worker |
| Experience | 38 Years |
| Location | 1514 Jefferson Hwy, New Orleans, Louisiana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144328386 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 002649 (Louisiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ochsner Clinic Foundation | New orleans, LA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ochsner Clinic Llc | 8224933619 | 2403 |
News Archive
Genetics may play a role in determining whether patients experience chronic pain after surgery, suggests a study published today in the Online First edition of Anesthesiology, the peer-reviewed medical journal of the American Society of Anesthesiologists
TxCell SA, a biotechnology company developing innovative, personalized cellular immunotherapies using regulatory T cells to treat severe chronic inflammatory and autoimmune diseases, today announces the signature of a strategic R&D collaboration agreement with the Lübeck Institute of Experimental Dermatology, a leading institution in the field of translational research on skin blistering diseases, part of the University of Lübeck in Germany.
A staggering 1.7 million persons in the United States will be diagnosed with cancer in 2016, with 600,000 cases ending in death. University of Oklahoma researchers have collaborated to design a novel, non-invasive cancer therapy that could eliminate tumors without affecting the healthy cells in the body.
A combination of two drugs works better than either drug alone for patients with renal cell carcinoma, the most common form of kidney cancer, according to a pilot study led by Duke University Comprehensive Cancer Center researchers.
A group of researchers at Immunology Frontier Research Center (IFReC), Osaka University and RIKEN Center for Integrative Medical Sciences jointly clarified the mechanism for inducing germinal-center B cells' differentiation into memory B cells, immune cells that remember antigens, at the molecular level.
› Verified 1 days ago
| Entity Name | Ochsner Clinic Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538151428 PECOS PAC ID: 8224933619 Enrollment ID: O20031126000513 |
News Archive
Genetics may play a role in determining whether patients experience chronic pain after surgery, suggests a study published today in the Online First edition of Anesthesiology, the peer-reviewed medical journal of the American Society of Anesthesiologists
TxCell SA, a biotechnology company developing innovative, personalized cellular immunotherapies using regulatory T cells to treat severe chronic inflammatory and autoimmune diseases, today announces the signature of a strategic R&D collaboration agreement with the Lübeck Institute of Experimental Dermatology, a leading institution in the field of translational research on skin blistering diseases, part of the University of Lübeck in Germany.
A staggering 1.7 million persons in the United States will be diagnosed with cancer in 2016, with 600,000 cases ending in death. University of Oklahoma researchers have collaborated to design a novel, non-invasive cancer therapy that could eliminate tumors without affecting the healthy cells in the body.
A combination of two drugs works better than either drug alone for patients with renal cell carcinoma, the most common form of kidney cancer, according to a pilot study led by Duke University Comprehensive Cancer Center researchers.
A group of researchers at Immunology Frontier Research Center (IFReC), Osaka University and RIKEN Center for Integrative Medical Sciences jointly clarified the mechanism for inducing germinal-center B cells' differentiation into memory B cells, immune cells that remember antigens, at the molecular level.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Phyllis Shnaider, SW 1514 Jefferson Hwy, New Orleans, LA 70121-2429 Ph: (504) 842-4000 | Phyllis Shnaider, SW 1514 Jefferson Hwy, New Orleans, LA 70121-2429 Ph: (504) 842-4000 |
News Archive
Genetics may play a role in determining whether patients experience chronic pain after surgery, suggests a study published today in the Online First edition of Anesthesiology, the peer-reviewed medical journal of the American Society of Anesthesiologists
TxCell SA, a biotechnology company developing innovative, personalized cellular immunotherapies using regulatory T cells to treat severe chronic inflammatory and autoimmune diseases, today announces the signature of a strategic R&D collaboration agreement with the Lübeck Institute of Experimental Dermatology, a leading institution in the field of translational research on skin blistering diseases, part of the University of Lübeck in Germany.
A staggering 1.7 million persons in the United States will be diagnosed with cancer in 2016, with 600,000 cases ending in death. University of Oklahoma researchers have collaborated to design a novel, non-invasive cancer therapy that could eliminate tumors without affecting the healthy cells in the body.
A combination of two drugs works better than either drug alone for patients with renal cell carcinoma, the most common form of kidney cancer, according to a pilot study led by Duke University Comprehensive Cancer Center researchers.
A group of researchers at Immunology Frontier Research Center (IFReC), Osaka University and RIKEN Center for Integrative Medical Sciences jointly clarified the mechanism for inducing germinal-center B cells' differentiation into memory B cells, immune cells that remember antigens, at the molecular level.
› Verified 1 days ago
Dr. Rebecca Linnea Kendig, PH.D., LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 8620 Jeannette St, New Orleans, LA 70118 Phone: 504-292-1447 | |
Melissa Scheib, CSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 4919 Canal St, Suite 203, New Orleans, LA 70119 Phone: 504-483-9883 | |
Sarah Tebbe, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 2640 Canal St Ste 4, New Orleans, LA 70119 Phone: 504-821-2232 | |
Jacqueline Saunders, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 701 Loyola Ave Ste 108, New Orleans, LA 70113 Phone: 504-503-0878 Fax: 504-503-0893 | |
Ms. Monica Marie Mills-mattox, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 1050 S Jeff Davis Pkwy Ste 240, New Orleans, LA 70125 Phone: 832-725-0586 Fax: 888-977-1299 | |
John Maloney, LCSW Clinical Social Worker Medicare: May Accept Medicare Assignments Practice Location: 4316 State Street Dr, New Orleans, LA 70125 Phone: 504-722-7932 Fax: 337-443-2890 | |
Mrs. Shenicka Adams Varnado, LMSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 3801 Canal St, Suite 314, New Orleans, LA 70119 Phone: 504-483-7254 |